BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4510283)

  • 21. The effect of treatment with a combination of 6-mercaptopurine and porfiromycin on an established Friend leukemia virus infection.
    Sidwell RW; Dixon GJ; Compton P; Schabel FM
    Cancer Res; 1969 Mar; 29(3):497-502. PubMed ID: 5773795
    [No Abstract]   [Full Text] [Related]  

  • 22. Potentiating effect of benzo[a]pyrene and caffeine on Friend viral leukemogenesis.
    Raikow RB; Okunewick JP; Buffo MJ; Jones DL; Brozovich BJ; Seeman PR; Koval TM
    Carcinogenesis; 1981; 2(1):1-6. PubMed ID: 6268320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fluorescent antibody technic in Friend virus--infected tumor cells in rats].
    Saito H; Takeichi N; Sendo F; Kaji H; Kobayashi H
    Saishin Igaku; 1970 Nov; 25(11):2376-82. PubMed ID: 4920652
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunological senescence in mice and its reversal by coenzyme Q10.
    Bliznakov EG
    Mech Ageing Dev; 1978 Mar; 7(3):189-97. PubMed ID: 304510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on Friend leukemia virus infections in mice.
    Sidwell RW; Allen LB; Huffman JH; Witkowski JT; Sinon LN
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):854-8. PubMed ID: 1129309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of sex upon the development of Friend virus leukaemia.
    Gillespie AV; Rowson KE
    Int J Cancer; 1968 Nov; 3(6):867-75. PubMed ID: 5731986
    [No Abstract]   [Full Text] [Related]  

  • 27. Divergence between immunosuppression and immunocompetence during virus-induced leukemogenesis.
    Cerny J; McAlack RF; Geglowski WS; Friedman H
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1862-5. PubMed ID: 4942915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon and murine leukaemia. 3. Efficacy of interferon preparations administered after inoculation of Friend virus.
    Gresser I; Coppey J; Fontaine-Brouty-Boye D; Falcoff R; Falcoff E; Zajdela F
    Nature; 1967 Jul; 215(5097):174-5. PubMed ID: 6049109
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibitory effect of Friend leukemia virus infection on the antibody formation to sheep erythrocytes in mice.
    Odaka T; Ishi H; Yamaura K; Yamamoto T
    Jpn J Exp Med; 1966 Jun; 36(3):277-90. PubMed ID: 5296558
    [No Abstract]   [Full Text] [Related]  

  • 30. Elliptinium, norcantharidin and tetrachlordecaoxide in combined chemo-immunotherapy prolong the survival of Friend-virus-infected mice.
    Liu XH; Blazsek I; Breard J; Comisso M; Mathe G; Misset JL
    Drugs Exp Clin Res; 1991; 17(9):419-26. PubMed ID: 1822434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition and enhancement of Friend leukemia virus by pyran copolymer.
    Schuller GB; Morahan PS; Snodgrass M
    Cancer Res; 1975 Aug; 35(8):1915-20. PubMed ID: 1149015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Friend leukemia virus infection in germfree mice following antigen stimulation.
    Kouttab NM; Jutila JW
    J Immunol; 1972 Mar; 108(3):591-5. PubMed ID: 4551850
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of different erythropoietic homeostasis factors on the evolution of Friend's leukemia].
    Tambourin P; Wendling F; Barat N; Zajdela F
    Nouv Rev Fr Hematol; 1969; 9(4):461-84. PubMed ID: 4242782
    [No Abstract]   [Full Text] [Related]  

  • 34. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex.
    Lu L; Shen RN; Zhou SZ; Srivastava C; Harrington M; Miyazawa K; Wu B; Lin ZH; Ruscetti S; Broxmeyer HE
    Int J Hematol; 1991 Apr; 54(2):117-24. PubMed ID: 1660735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathology of spontaneous regression in virus-induced murine leukemia.
    Russo I; Russo J; Baldwin J; Rich MA
    Am J Pathol; 1976 Oct; 85(1):73-84. PubMed ID: 970443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a series of purine analogs on Friend leukemia virus infections in mice.
    Sidwell RW; Sellers SM; Dixon GJ; Schabel FM
    Cancer Res; 1968 Jan; 28(1):35-40. PubMed ID: 5635370
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on mice of a tumor resistant strain (X-Gf). 8. Type C particles in mammary tumors of Friend leukemia virus-infected mice.
    Goldfeder A; de Harven E; Friend C
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):323-8. PubMed ID: 4327596
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of established Friend virus leukemia by statolon. IV. Role of humoral antibody in the development of a dormant infection.
    Wheelock EF; Toy ST; Caroline NL; Sibal LR; Fink MA; Beverley PC; Allison AC
    J Natl Cancer Inst; 1972 Mar; 48(3):665-73. PubMed ID: 5062046
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of bone marrow graft on the susceptibility of mice to Friend leukemia virus.
    Odaka T
    Jpn J Exp Med; 1969 Feb; 39(1):99-100. PubMed ID: 4899616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.